| Name | Title | Contact Details |
|---|
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.
MyHealth Centre is a unique collaborative partnership of medical professionals and health care industry experts established in order to deliver quality and innovation in patient care. MyHealth Centre is a leading manager of independently owned diagnostic imaging facilities in Ontario. We currently manage over 25 Independent Health Facilities (IHFs) with agreements to develop additional IHF licenses.
Lyniate offers industry-leading interoperability solutions that deliver simple and seamless integration of all health data. With two Best-in-KLAS products, Lyniate Corepoint and Lyniate Rhapsody, we established a proven reputation on which we continue to build adaptable interoperability solutions that connect the healthcare ecosystem to unlock the full potential of data. We partner with providers, health plans, and health tech solutions around the world to enable rapid, reliable, and scalable interoperability, both vertically and horizontally, on-premises and in the cloud.
DPS Health is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BroMenn Healthcare System is a Normal, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.